PACS Group, Inc.
PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. It also provides senior care and independent living facilities. The company engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is headquartered in Farmington, Utah.
PACS Group, Inc. (PACS) - Net Assets
Latest net assets as of September 2025: $876.92 Million USD
Based on the latest financial reports, PACS Group, Inc. (PACS) has net assets worth $876.92 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($5.63 Billion) and total liabilities ($4.75 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $876.92 Million |
| % of Total Assets | 15.58% |
| Annual Growth Rate | 118.41% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 273.87 |
PACS Group, Inc. - Net Assets Trend (2022–2025)
This chart illustrates how PACS Group, Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for PACS Group, Inc. (2022–2025)
The table below shows the annual net assets of PACS Group, Inc. from 2022 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $715.69 Million | 0.00% |
| 2024-12-31 | $715.69 Million | +603.55% |
| 2023-12-31 | $101.73 Million | +48.18% |
| 2022-12-31 | $68.65 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to PACS Group, Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 85.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $118.04 Million | 16.64% |
| Common Stock | $155.00K | 0.02% |
| Other Components | $591.36 Million | 83.34% |
| Total Equity | $709.55 Million | 100.00% |
PACS Group, Inc. Competitors by Market Cap
The table below lists competitors of PACS Group, Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Xinxing Ductile Iron Pipes Co Ltd
SHE:000778
|
$1.51 Billion |
|
Laboratorios Farmaceuticos Rovi S.A
PINK:LABFF
|
$1.51 Billion |
|
Sirius Real Estate Limited
PINK:SRRLF
|
$1.51 Billion |
|
Maze Therapeutics, Inc. Common Stock
NASDAQ:MAZE
|
$1.51 Billion |
|
Chongqing Brewery Co Ltd
SHG:600132
|
$1.51 Billion |
|
Ajanta Pharma Limited
NSE:AJANTPHARM
|
$1.51 Billion |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
|
$1.51 Billion |
|
Carmila SA
PA:CARM
|
$1.51 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in PACS Group, Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 709,554,000 to 709,554,000, a change of 0 (0.0%).
- Net income of 55,760,000 contributed positively to equity growth.
- Dividend payments of 33,721,000 reduced retained earnings.
- Other factors decreased equity by 22,039,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $55.76 Million | +7.86% |
| Dividends Paid | $33.72 Million | -4.75% |
| Other Changes | $-22.04 Million | -3.11% |
| Total Change | $- | 0.00% |
Book Value vs Market Value Analysis
This analysis compares PACS Group, Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 7.34x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 82.69x to 7.34x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-12-31 | $0.42 | $35.05 | x |
| 2023-12-31 | $0.64 | $35.05 | x |
| 2024-12-31 | $4.57 | $35.05 | x |
| 2025-12-31 | $4.78 | $35.05 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently PACS Group, Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 7.86%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.36%
- • Asset Turnover: 0.78x
- • Equity Multiplier: 7.39x
- Recent ROE (7.86%) is below the historical average (92.40%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | 236.46% | 6.21% | 0.98x | 38.68x | $144.13 Million |
| 2023 | 117.42% | 3.63% | 0.89x | 36.54x | $103.26 Million |
| 2024 | 7.86% | 1.36% | 0.78x | 7.39x | $-15.20 Million |
| 2025 | 7.86% | 1.36% | 0.78x | 7.39x | $-15.20 Million |
Industry Comparison
This section compares PACS Group, Inc.'s net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $243,584,061
- Average return on equity (ROE) among peers: -1.00%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| PACS Group, Inc. (PACS) | $876.92 Million | 236.46% | 5.42x | $1.51 Billion |
| Addus HomeCare Corporation (ADUS) | $175.08 Million | 7.77% | 0.53x | $1.74 Billion |
| agilon health Inc (AGL) | $470.95 Million | -55.24% | 2.68x | $161.08 Million |
| Airsculpt Technologies Inc (AIRS) | $83.53 Million | 12.63% | 1.40x | $17.33 Million |
| Amedisys Inc (AMED) | $397.76 Million | 3.21% | 0.68x | $3.26 Billion |
| AMN Healthcare Services Inc (AMN) | $116.10 Million | 32.55% | 1.62x | $624.22 Million |
| American Shared Hospital Service (AMS) | $25.18 Million | -6.04% | 1.15x | $8.12 Million |
| American Oncology Network Inc. (AONC) | $70.71 Million | -7.84% | 4.30x | $112.23 Million |
| Ardent Health Partners, Inc. (ARDT) | $760.28 Million | -4.69% | 2.12x | $224.01 Million |
| Arem Pacific Corporation (ARPC) | $-60.56K | 0.00% | 0.00x | $246.12K |
| Astrana Health Inc (ASTH) | $336.31 Million | 7.67% | 0.46x | $1.07 Billion |